Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Daumer

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2011
HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosisF Möller, J Poettgen, F Broemel, et al.
Neurology|May 16, 2008
Disability as an outcome in MS clinical trialsG C Ebers, L Heigenhauser, M Daumer, et al.
Biomedizinische Technik. Biomedical Engineering|December 22, 1998
[Automatic EEG data processing in a multicenter study]W Nahm, G Stockmanns, M Daumer, et al.
Experimental Cell Research|February 2, 2002
AP-1 transcription factor complex is a target of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesisA Cevik Tufan, Kathleen M Daumer, Anthony M DeLise, et al.
Neurology|September 16, 2011
Age and disability accumulation in multiple sclerosisA Scalfari, A Neuhaus, M Daumer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2006
Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantationM Daumer, L M Griffith, W Meister, et al.
BMC Medical Informatics and Decision Making|May 10, 2007
Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple SclerosisM Daumer, A Neuhaus, C Lederer, et al.
Journal of Cancer|March 6, 2013
Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomyBldm Brücher, A Stojadinovic, A Bilchik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
The relationship of age with the clinical phenotype in multiple sclerosisA Scalfari, C Lederer, M Daumer, et al.
Biomedizinische Technik. Biomedical Engineering|January 5, 2002
[Concept for an internet-based databank for supporting projects in the area of biosignal analysis]M Daumer, W Nahm, M Scholz, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2011
HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosisF Möller, J Poettgen, F Broemel, et al.
Neurology|May 16, 2008
Disability as an outcome in MS clinical trialsG C Ebers, L Heigenhauser, M Daumer, et al.
Biomedizinische Technik. Biomedical Engineering|December 22, 1998
[Automatic EEG data processing in a multicenter study]W Nahm, G Stockmanns, M Daumer, et al.
Experimental Cell Research|February 2, 2002
AP-1 transcription factor complex is a target of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesisA Cevik Tufan, Kathleen M Daumer, Anthony M DeLise, et al.
Neurology|September 16, 2011
Age and disability accumulation in multiple sclerosisA Scalfari, A Neuhaus, M Daumer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2006
Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantationM Daumer, L M Griffith, W Meister, et al.
BMC Medical Informatics and Decision Making|May 10, 2007
Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple SclerosisM Daumer, A Neuhaus, C Lederer, et al.
Journal of Cancer|March 6, 2013
Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomyBldm Brücher, A Stojadinovic, A Bilchik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
The relationship of age with the clinical phenotype in multiple sclerosisA Scalfari, C Lederer, M Daumer, et al.
Biomedizinische Technik. Biomedical Engineering|January 5, 2002
[Concept for an internet-based databank for supporting projects in the area of biosignal analysis]M Daumer, W Nahm, M Scholz, et al.
Pageof 4